First American Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
20,828
-132
| -0.6% | -$71.6K | 0.69% | 43 |
|
|
2025
Q4 | $12.1M | Sell |
20,960
-302
| -1% | -$171K | 0.83% | 32 |
|
|
2025
Q3 | $10.3M | Buy |
21,262
+162
| +0.8% | +$75.4K | 0.75% | 38 |
|
|
2025
Q2 | $8.56M | Sell |
21,100
-204
| -1% | -$85.3K | 0.68% | 48 |
|
|
2025
Q1 | $10.6M | Buy |
21,304
+5,149
| +32% | +$2.79M | 0.97% | 29 |
|
|
2024
Q4 | $8.4M | Sell |
16,155
-6
| -0% | -$3.3K | 0.84% | 37 |
|
|
2024
Q3 | $10M | Sell |
16,161
-2,227
| -12% | -$1.32M | 0.99% | 31 |
|
|
2024
Q2 | $10.2M | Buy |
18,388
+880
| +5% | +$504K | 1.02% | 28 |
|
|
2024
Q1 | $10.2M | Buy |
17,508
+1,149
| +7% | +$645K | 1.07% | 29 |
|
|
2023
Q4 | $8.68M | Sell |
16,359
-407
| -2% | -$197K | 1.07% | 32 |
|
|
2023
Q3 | $8.49M | Sell |
16,766
-135
| -0.8% | -$71.9K | 1.2% | 26 |
|
|
2023
Q2 | $8.82M | Buy |
16,901
+766
| +5% | +$413K | 1.21% | 23 |
|
|
2023
Q1 | $9.3M | Buy |
16,135
+3,688
| +30% | +$2.08M | 1.38% | 22 |
|
|
2022
Q4 | $6.86M | Buy |
12,447
+2,473
| +25% | +$1.31M | 1.06% | 34 |
|
|
2022
Q3 | $5.06M | Sell |
9,974
-135
| -1% | -$75.5K | 0.85% | 47 |
|
|
2022
Q2 | $5.49M | Buy |
10,109
+437
| +5% | +$241K | 0.87% | 47 |
|
|
2022
Q1 | $5.71M | Buy |
9,672
+300
| +3% | +$172K | 0.79% | 51 |
|
|
2021
Q4 | $6.25M | Buy |
9,372
+314
| +3% | +$196K | 0.85% | 40 |
|
|
2021
Q3 | $5.17M | Buy |
9,058
+355
| +4% | +$195K | 0.78% | 49 |
|
|
2021
Q2 | $4.39M | Sell |
8,703
-348
| -4% | -$164K | 0.69% | 54 |
|
|
2021
Q1 | $4.13M | Sell |
9,051
-4
| -0% | -$1.91K | 0.65% | 58 |
|
|
2020
Q4 | $4.22M | Sell |
9,055
-4,600
| -34% | -$2.16M | 0.7% | 50 |
|
|
2020
Q3 | $6.03M | Buy |
13,655
+82
| +0.6% | +$33.9K | 1.08% | 26 |
|
|
2020
Q2 | $4.92M | Buy |
13,573
+556
| +4% | +$186K | 0.96% | 37 |
|
|
2020
Q1 | $3.69M | Buy |
13,017
+184
| +1% | +$58K | 0.9% | 39 |
|
|
2019
Q4 | $4.17M | Buy |
12,833
+70
| +0.5% | +$21.2K | 0.8% | 52 |
|
|
2019
Q3 | $3.72M | Buy |
12,763
+11
| +0.1% | +$3.15K | 0.75% | 55 |
|
|
2019
Q2 | $3.75M | Buy |
12,752
+557
| +5% | +$153K | 0.78% | 54 |
|
|
2019
Q1 | $3.34M | Buy |
12,195
+301
| +3% | +$74.9K | 0.74% | 54 |
|
|
2018
Q4 | $2.66M | Sell |
11,894
-338
| -3% | -$79.3K | 0.67% | 54 |
|
|
2018
Q3 | $2.99M | Sell |
12,232
-5,266
| -30% | -$1.21M | 0.67% | 54 |
|
|
2018
Q2 | $3.62M | Buy |
17,498
+529
| +3% | +$112K | 0.85% | 45 |
|
|
2018
Q1 | $3.5M | Sell |
16,969
-4
| -0% | -$840 | 0.85% | 43 |
|
|
2017
Q4 | $3.22M | Buy |
16,973
+387
| +2% | +$74.1K | 0.79% | 49 |
|
|
2017
Q3 | $3.14M | Buy |
16,586
+573
| +4% | +$104K | 0.82% | 51 |
|
|
2017
Q2 | $2.79M | Buy |
16,013
+5,482
| +52% | +$921K | 0.78% | 55 |
|
|
2017
Q1 | $1.62M | Sell |
10,531
-547
| -5% | -$83.6K | 0.49% | 66 |
|
|
2016
Q4 | $1.56M | Sell |
11,078
-520
| -4% | -$76.7K | 0.48% | 70 |
|
|
2016
Q3 | $1.84M | Sell |
11,598
-6,910
| -37% | -$1.06M | 0.58% | 67 |
|
|
2016
Q2 | $2.73M | Sell |
18,508
-1,019
| -5% | -$150K | 0.97% | 45 |
|
|
2016
Q1 | $2.77M | Buy |
19,527
+290
| +2% | +$38.9K | 0.97% | 49 |
|
|
2015
Q4 | $2.73M | Sell |
19,237
-282
| -1% | -$37.6K | 1.01% | 45 |
|
|
2015
Q3 | $2.39M | Buy |
19,519
+80
| +0.4% | +$10.4K | 0.92% | 49 |
|
|
2015
Q2 | $2.52M | Sell |
19,439
-695
| -3% | -$90.6K | 0.93% | 50 |
|
|
2015
Q1 | $2.7M | Sell |
20,134
-361
| -2% | -$46.5K | 0.96% | 49 |
|
|
2014
Q4 | $2.57M | Sell |
20,495
-10,504
| -34% | -$1.28M | 0.95% | 50 |
|
|
2014
Q3 | $3.77M | Sell |
30,999
-75
| -0.2% | -$9.12K | 1.4% | 31 |
|
|
2014
Q2 | $3.67M | Buy |
31,074
+174
| +0.6% | +$20.5K | 1.39% | 33 |
|
|
2014
Q1 | $3.71M | Buy |
30,900
+5,770
| +23% | +$686K | 1.39% | 30 |
|
|
2013
Q4 | $2.8M | Sell |
25,130
-520
| -2% | -$51.7K | 0.94% | 49 |
|
|
2013
Q3 | $2.36M | Sell |
25,650
-1,296
| -5% | -$117K | 0.85% | 51 |
|
|
2013
Q2 | $2.28M | Buy |
+26,946
| New | +$2.24M | 0.86% | 50 |
|
Other funds holding TMO
VCM
First American Trust's TMO Position: Q1 2026 in Review
First American Trust reduced its Thermo Fisher Scientific (TMO) stake by 0.63% in Q1 2026, selling an estimated $71.6K and leaving 20,828 shares worth $10.2M. The position accounts for 0.69% of the portfolio, ranked #43.
First American Trust first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.1M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- First American Trust held 20,828 shares of Thermo Fisher Scientific worth $10.2M as of Q1 2026.
- First American Trust sold 132 Thermo Fisher Scientific shares in Q1 2026, an estimated $71.6K.
- Thermo Fisher Scientific made up 0.69% of First American Trust's portfolio in Q1 2026, its #43 holding.
- First American Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- First American Trust's Thermo Fisher Scientific position peaked at $12.1M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.